HEAD AND NECK CANCERS- SQUAMOUS CELL
Clinical trials for HEAD AND NECK CANCERS- SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS- SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS- SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection combo shows promise against head and neck cancer
Disease control Recruiting nowThis early-phase study tests a new drug, VLPONC-01, injected directly into head and neck tumors to see if it's safe and can shrink tumors. About 41 adults with advanced head and neck cancer will receive the injection alone or with an immunotherapy drug (pembrolizumab). The goal i…
Matched conditions: HEAD AND NECK CANCERS- SQUAMOUS CELL
Phase: PHASE1 • Sponsor: VLP Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
New blood test could forecast head and neck cancer progression
Knowledge-focused Recruiting nowThis observational study enrolls 30 adults with recurrent or metastatic head and neck squamous cell carcinoma. Researchers will collect blood samples to measure circulating tumor cells and immune cell activity, aiming to link these markers with how long patients live without the …
Matched conditions: HEAD AND NECK CANCERS- SQUAMOUS CELL
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 08:53 UTC